| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/13/2004 | CN1537115A C2,5'-disubstituted and N6, C2, 5' trisubstituted adenosine derivatives and their different uses |
| 10/13/2004 | CN1537105A Quinazolines as MMP-13 inhibitors |
| 10/13/2004 | CN1537103A Kinetic resolution of intermediater body for preparing benazepril and its analogues |
| 10/13/2004 | CN1537102A Ortho-substituted nitrogen-containing bisaryl compounds used as potassium channel inhibitors |
| 10/13/2004 | CN1537101A Pyridine matrix metalloproteinase inhibitors |
| 10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 10/13/2004 | CN1537099A Process for preparation of 3-spiro'cyclohexam-1, 3'-'3H indolin-2'-one derivatives |
| 10/13/2004 | CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 10/13/2004 | CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 10/13/2004 | CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor |
| 10/13/2004 | CN1537014A HMGB1 protein inhibitors and/or antagonisis for treatment vascular diseases |
| 10/13/2004 | CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method |
| 10/13/2004 | CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases |
| 10/13/2004 | CN1537002A Novel theterocyclic analogs of diphenylethylene compounds |
| 10/13/2004 | CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 10/13/2004 | CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists |
| 10/13/2004 | CN1536996A (-)-olivil as antioxidant |
| 10/13/2004 | CN1536994A Hypoglycemic agent |
| 10/13/2004 | CN1536991A (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 10/13/2004 | CN1536990A Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 10/13/2004 | CN1535983A Blood vessel generating inhibitor |
| 10/13/2004 | CN1535969A Total alkaloid of xiatianwu (a Chinese medicinal material), its preparation method and application |
| 10/13/2004 | CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative |
| 10/13/2004 | CN1535957A New isoquinoline compounds, their preparation method and medicine composition contaning them |
| 10/13/2004 | CN1535718A Houpo Huanglian Ye (magnolia coptis liguor) |
| 10/13/2004 | CN1535713A Yixintong dripping pill and its preparation method |
| 10/13/2004 | CN1535622A Processing process for making beverage and food by using duck wheat as raw material |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170846C Giant-web bominator angiectasis factor and its prepn and gene |
| 10/13/2004 | CN1170827C Benzofurylpyrone deriuvatives |
| 10/13/2004 | CN1170817C 前列腺素e类似物 E prostaglandin analogs |
| 10/13/2004 | CN1170811C Branched chain amino acid-dependent aminotransferase inhibitors and their use in treatment of diabetic retinopathy |
| 10/13/2004 | CN1170576C Xinning capsule |
| 10/13/2004 | CN1170571C Diles treating medicine and its prepn. |
| 10/13/2004 | CN1170563C Blood pressure stabilizing pill |
| 10/13/2004 | CN1170557C Medicine for treating cardio-cerebro vascular disease |
| 10/13/2004 | CN1170537C Substituted 1-(piperidin-4-yl)3-(aryl)-isothioureas, ther prepn. and therapeutic use |
| 10/12/2004 | US6803480 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803365 Imidazo[1,3,5]triazinones and the use thereof |
| 10/12/2004 | US6803362 Heterocyclic compounds |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/07/2004 | WO2004085647A1 Low-molecular weight peptides inhibiting ion channel activity |
| 10/07/2004 | WO2004085630A1 Perivascular mesenchymal precursor cells |
| 10/07/2004 | WO2004085452A1 Compound having affinity with calcified tissue |
| 10/07/2004 | WO2004085440A1 Benzofuro-1,4-diazepin-2-one derivatives |
| 10/07/2004 | WO2004085420A1 Bicyclic compounds useful as angiotensin ii agonists |
| 10/07/2004 | WO2004085396A1 Preventive or therapeutic agent for ischemia/reperfusion injury, organ preservative, and screening method |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084932A2 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 10/07/2004 | WO2004084921A1 Perivascular mesenchymal precursor cell induced blood vessel formation |
| 10/07/2004 | WO2004084910A1 Compositions for treating angina |
| 10/07/2004 | WO2004084907A2 ACTIVATION SPECIFIC INHIBITORS OF NF-kB AND METHOD OF TREATING INFLAMMATORY PROCESSES IN CARDIO-VASCULAR DISEASES |
| 10/07/2004 | WO2004084906A1 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 10/07/2004 | WO2004069999A3 Screening method |
| 10/07/2004 | WO2004060362B1 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β |
| 10/07/2004 | WO2004048386A3 THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AND THIENO[2,3-b]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS |
| 10/07/2004 | WO2004045518A3 Open chain prolyl urea-related modulators of androgen receptor function |
| 10/07/2004 | WO2004002418A3 Compositions and methods comprising protein activated receptor antagonists |
| 10/07/2004 | WO2003099195A3 Immunomodulatory compounds and methods of use thereof |
| 10/07/2004 | WO2003076427A8 Quinazoline compounds useful in therapy |
| 10/07/2004 | WO2003068757A9 Novel pyridin- and pyrimidin-derivatives |
| 10/07/2004 | WO2003068748A9 Novel pyridine- and quinoline-derivatives |
| 10/07/2004 | WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 10/07/2004 | WO2003053973A8 Pyrazolyl-substituted triazoloquinoxalines |
| 10/07/2004 | WO2003049679A3 Mitotic kinesin inhibitors |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198832 Compositions and methods for treating amyloidosis |
| 10/07/2004 | US20040198827 Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases |
| 10/07/2004 | US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects |
| 10/07/2004 | US20040198812 Pseudopolymorphic forms of carvedilol |
| 10/07/2004 | US20040198807 mixture of ferulic acid with caffeic and, or chlorogenic acid; food, beverage |
| 10/07/2004 | US20040198804 i.e., 3-[3,5-dimethyl-4-[3-oxo-3-(piperazin-1-ylpropyl]-1H-pyrrol-2-ylmethylene]-1,3-dihydroindol-2-one, in which the piperazine may be 4-substituted with methyl or ethyl and salts are tyrosine kinase inhibitors used to treat various kinds of cancer |
| 10/07/2004 | US20040198792 Imidazole derivatives modulating the sodium channels |
| 10/07/2004 | US20040198791 Fused imidazole derivative |
| 10/07/2004 | US20040198788 Synergistic mixture with acylcoenzyme: cholesterol transferase inhibitor; arteriosclerosis; antiischemic agents; cardiovascular disorders |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198774 Preventive and/or remedial agent for disease attributable to arteriosclerotic activity |
| 10/07/2004 | US20040198771 medical equipment for angioplasty |
| 10/07/2004 | US20040198766 Chemical compounds |
| 10/07/2004 | US20040198757 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 10/07/2004 | US20040198751 Pyrazolo-pyrimidine compound; anticancer agents |
| 10/07/2004 | US20040198747 Sodium channel blockers |
| 10/07/2004 | US20040198746 Sodium channel blockers |
| 10/07/2004 | US20040198745 Sodium channel blockers |
| 10/07/2004 | US20040198744 Methods of using phenolic guanidine sodium channel blockers |
| 10/07/2004 | US20040198740 Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 |
| 10/07/2004 | US20040198738 Preventives or remedies for diseaes caused by enos expression |
| 10/07/2004 | US20040198737 Azaindoles |
| 10/07/2004 | US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 10/07/2004 | US20040198733 Obesity; antidiabetic agents; cardiovascular disorders; antilipemic agentsl circadian rhythm disorders; hypotensive agents; antidepressants; anxiolytic agents |
| 10/07/2004 | US20040198732 Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals |
| 10/07/2004 | US20040198731 Antidiabetic agents; cardiovascular disorders; anticholesterol agents; antidepressants; schizophrenia; antilipemic agents; circidian rhythm disorders |
| 10/07/2004 | US20040198730 Pyridylfurans and pyrroles as raf kinase inhibitors |
| 10/07/2004 | US20040198726 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists |
| 10/07/2004 | US20040198720 3-(Arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 10/07/2004 | US20040198718 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
| 10/07/2004 | US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders |